Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer.

ABSTRACT: Ovarian cancer (OC) is the deadliest gynecological malignancy in developed countries and is the seventh-highest cause of death in women diagnosed with cancer worldwide. Currently, several therapies are in use against OC, including debulking surgery, chemotherapy, as well as targeted therapies. Even though the current standard-of-care therapies improve survival, a vast majority of OC patients relapse. Additionally, immunotherapies have only resulted in meager patient outcomes, potentially owing to the intricate immunosuppressive nexus within the tumor microenvironment. In this scenario, dendritic cell (DC) vaccination could serve as a potential addition to the therapeutic options available against OC. In this review, we provide an overview of current therapies in OC, focusing on immunothera

SUBMITTER: Caro AA 

PROVIDER: S-EPMC9406463 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature